Page last updated: 2024-08-16

sulfadiazine and cephalexin

sulfadiazine has been researched along with cephalexin in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's1 (9.09)18.2507
2000's5 (45.45)29.6817
2010's2 (18.18)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Davis, WD; Hines, C1
Bourdeau, P; Pellerin, JL; Person, JM; Sebbag, H1
Honkanen-Buzalski, T; Lehtolainen, T; Pyörälä, S; Shpigel, NY; Shwimmer, A1
Guo, J; Ni, BJ; Wang, B; Yuan, Z1
Guo, J; Li, H; Liu, T; Wang, B1

Reviews

1 review(s) available for sulfadiazine and cephalexin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

10 other study(ies) available for sulfadiazine and cephalexin

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Ehlers-Danlos syndrome with megaduodenum and malabsorption syndrome secondary to bacterial overgrowth. A report of the first case.
    The American journal of medicine, 1973, Volume: 54, Issue:4

    Topics: Cephalexin; Duodenal Diseases; Ehlers-Danlos Syndrome; Escherichia coli Infections; Female; Humans; Kanamycin; Malabsorption Syndromes; Middle Aged; Sulfadiazine

1973
Epidemiosurveillance of antimicrobial compound resistance of Staphylococcus intermedium clinical isolates from canine pyodermas.
    Comparative immunology, microbiology and infectious diseases, 1998, Volume: 21, Issue:2

    Topics: Aminoglycosides; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Cephalexin; Chloramphenicol; Dog Diseases; Dogs; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; France; Fusidic Acid; Macrolides; Microbial Sensitivity Tests; Oxacillin; Pyoderma; Retrospective Studies; Sentinel Surveillance; Staphylococcal Infections; Staphylococcus; Sulfadiazine; Tetracyclines; Trimethoprim

1998
In vitro antimicrobial susceptibility of Escherichia coli isolates from clinical bovine mastitis in Finland and Israel.
    Journal of dairy science, 2003, Volume: 86, Issue:12

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Ceftazidime; Cephalexin; Ciprofloxacin; Dihydrostreptomycin Sulfate; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Female; Finland; Gentamicins; Israel; Mastitis, Bovine; Microbial Sensitivity Tests; Sulfadiazine; Tetracycline; Trimethoprim

2003
Unravelling kinetic and microbial responses of enriched nitrifying sludge under long-term exposure of cephalexin and sulfadiazine.
    Water research, 2020, Apr-15, Volume: 173

    Topics: Ammonia; Bioreactors; Cephalexin; Nitrification; Oxidation-Reduction; RNA, Ribosomal, 16S; Sewage; Sulfadiazine

2020
Enhanced removal of cephalexin and sulfadiazine in nitrifying membrane-aerated biofilm reactors.
    Chemosphere, 2021, Volume: 263

    Topics: Biofilms; Bioreactors; Cephalexin; Nitrification; Sulfadiazine

2021